{"count": 25, "results": [{"_id": "34386197", "pmid": 34386197, "pmcid": "PMC8327221", "title": "Metformin improves FOXP3 mRNA expression through suppression of interferon gamma levels in pristane-induced murine models of lupus", "journal": "F1000Res", "authors": ["Sumantri S", "Hatta M", "Natzir R", "Rasyid H", "Rengganis I", "Massi MN", "Islam AA", "Lawrence G", "Patellongi I", "Benyamin AF"], "date": "2020-05-11T00:00:00Z", "doi": "10.12688/f1000research.23471.2", "meta_date_publication": "2020", "meta_volume": "9", "meta_issue": "", "meta_pages": "342", "score": 50281.12, "text_hl": " Background:  A recent study has indicated the potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy for @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus@@@ in animal models, but there has been no study evaluating the effect on @CHEMICAL_pristane @CHEMICAL_MESH:C009042 @@@pristane@@@-induced @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus@@@. ", "citations": {"NLM": "Sumantri S, Hatta M, Natzir R, Rasyid H, Rengganis I, Massi MN, Islam AA, Lawrence G, Patellongi I, Benyamin AF. Metformin improves FOXP3 mRNA expression through suppression of interferon gamma levels in pristane-induced murine models of lupus F1000Res. 2020;9():342. PMID: 34386197", "BibTeX": "@article{34386197, title={Metformin improves FOXP3 mRNA expression through suppression of interferon gamma levels in pristane-induced murine models of lupus}, author={Sumantri S and Hatta M and Natzir R and Rasyid H and Rengganis I and Massi MN and Islam AA and Lawrence G and Patellongi I and Benyamin AF}, journal={F1000Res}, volume={9}, pages={342}}"}}, {"_id": "34619975", "pmid": 34619975, "title": "Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus.", "journal": "Antioxid Redox Signal", "authors": ["Teng X", "Brown J", "Morel L"], "date": "2022-03-01T00:00:00Z", "doi": "10.1089/ars.2021.0070", "meta_date_publication": "2022 Mar", "meta_volume": "36", "meta_issue": "7-9", "meta_pages": "462-479", "score": 50264.215, "text_hl": "Redox Homeostasis Involvement in the Pharmacological Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@Systemic Lupus Erythematosus@@@.", "citations": {"NLM": "Teng X, Brown J, Morel L. Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus. Antioxid Redox Signal. 2022 Mar;36(7-9):462-479. PMID: 34619975", "BibTeX": "@article{34619975, title={Redox Homeostasis Involvement in the Pharmacological Effects of Metformin in Systemic Lupus Erythematosus.}, author={Teng X and Brown J and Morel L}, journal={Antioxid Redox Signal}, volume={36}, number={7-9}, pages={462-479}}"}}, {"_id": "34874833", "pmid": 34874833, "title": "Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis.", "journal": "Clin Exp Rheumatol", "authors": ["Sun F", "Zhang D", "Wang H", "Wang H", "Liu Z", "Geng S", "Wang X", "Li T", "Wan W", "Lu L", "Teng X", "Morel L", "Ye S"], "date": "2022-09-01T00:00:00Z", "doi": "10.55563/clinexprheumatol/7y5ku8", "meta_date_publication": "2022 Sep", "meta_volume": "40", "meta_issue": "9", "meta_pages": "1733-1737", "score": 50262.297, "text_hl": "Attaining treat-to-target endpoints with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus@@@ @SPECIES_9606 @@@patients@@@: a pooled analysis.", "citations": {"NLM": "Sun F, Zhang D, Wang H, Wang H, Liu Z, Geng S, Wang X, Li T, Wan W, Lu L, Teng X, Morel L, Ye S. Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis. Clin Exp Rheumatol. 2022 Sep;40(9):1733-1737. PMID: 34874833", "BibTeX": "@article{34874833, title={Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis.}, author={Sun F and Zhang D and Wang H and Wang H and Liu Z and Geng S and Wang X and Li T and Wan W and Lu L and Teng X and Morel L and Ye S}, journal={Clin Exp Rheumatol}, volume={40}, number={9}, pages={1733-1737}}"}}, {"_id": "34879473", "pmid": 34879473, "pmcid": "PMC8747910", "title": "Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease", "journal": "Korean J Intern Med", "authors": ["Kim JW", "Choe JY", "Park SH"], "date": "2022-01-01T00:00:00Z", "doi": "10.3904/kjim.2021.363", "meta_date_publication": "2022 Jan", "meta_volume": "37", "meta_issue": "1", "meta_pages": "13-26", "score": 50260.11, "text_hl": "In experiments with @SPECIES_10090 @@@murine@@@ @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@SLE@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D0", "citations": {"NLM": "Kim JW, Choe JY, Park SH. Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease Korean J Intern Med. 2022 Jan;37(1):13-26. PMID: 34879473", "BibTeX": "@article{34879473, title={Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease}, author={Kim JW and Choe JY and Park SH}, journal={Korean J Intern Med}, volume={37}, number={1}, pages={13-26}}"}}, {"_id": "38268156", "pmid": 38268156, "title": "Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial.", "journal": "Lancet Rheumatol", "authors": ["Sun F", "Wang HJ", "Liu Z", "Geng S", "Wang HT", "Wang X", "Li T", "Morel L", "Wan W", "Lu L", "Teng X", "Ye S"], "date": "2020-04-01T00:00:00Z", "doi": "10.1016/S2665-9913(20)30004-7", "meta_date_publication": "2020 Apr", "meta_volume": "2", "meta_issue": "4", "meta_pages": "e210-e216", "score": 50257.0, "text_hl": "Safety and efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@systemic lupus erythematosus@@@: a multicentre, randomised, double-blind, placebo-controlled trial.", "citations": {"NLM": "Sun F, Wang HJ, Liu Z, Geng S, Wang HT, Wang X, Li T, Morel L, Wan W, Lu L, Teng X, Ye S. Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2020 Apr;2(4):e210-e216. PMID: 38268156", "BibTeX": "@article{38268156, title={Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial.}, author={Sun F and Wang HJ and Liu Z and Geng S and Wang HT and Wang X and Li T and Morel L and Wan W and Lu L and Teng X and Ye S}, journal={Lancet Rheumatol}, volume={2}, number={4}, pages={e210-e216}}"}}, {"_id": "31904843", "pmid": 31904843, "title": "Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.", "journal": "Rheumatology (Oxford)", "authors": ["Jang SG", "Lee J", "Hong SM", "Kwok SK", "Cho ML", "Park SH"], "date": "2020-06-01T00:00:00Z", "doi": "10.1093/rheumatology/kez631", "meta_date_publication": "2020 Jun 1", "meta_volume": "59", "meta_issue": "6", "meta_pages": "1426-1438", "score": 50254.508, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through @GENE_STAT1 @GENE_20846 @@@STAT1@@@ in an animal model of @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus@@@.", "citations": {"NLM": "Jang SG, Lee J, Hong SM, Kwok SK, Cho ML, Park SH. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus. Rheumatology (Oxford). 2020 Jun 1;59(6):1426-1438. PMID: 31904843", "BibTeX": "@article{31904843, title={Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.}, author={Jang SG and Lee J and Hong SM and Kwok SK and Cho ML and Park SH}, journal={Rheumatology (Oxford)}, volume={59}, number={6}, pages={1426-1438}}"}}, {"_id": "33093216", "pmid": 33093216, "pmcid": "PMC7583791", "title": "Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials", "journal": "Lupus Sci Med", "authors": ["Sun F", "Geng S", "Wang H", "Wang H", "Liu Z", "Wang X", "Li T", "Wan W", "Lu L", "Teng X", "Morel L", "Ye S"], "date": "2020-10-01T00:00:00Z", "doi": "10.1136/lupus-2020-000429", "meta_date_publication": "2020 Oct", "meta_volume": "7", "meta_issue": "1", "meta_pages": "", "score": 50253.863, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on disease flares in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@systemic lupus erythematosus@@@: post hoc analyses from two randomised trials", "citations": {"NLM": "Sun F, Geng S, Wang H, Wang H, Liu Z, Wang X, Li T, Wan W, Lu L, Teng X, Morel L, Ye S. Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials Lupus Sci Med. 2020 Oct;7(1):. PMID: 33093216", "BibTeX": "@article{33093216, title={Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials}, author={Sun F and Geng S and Wang H and Wang H and Liu Z and Wang X and Li T and Wan W and Lu L and Teng X and Morel L and Ye S}, journal={Lupus Sci Med}, volume={7}, number={1}}"}}, {"_id": "40659125", "pmid": 40659125, "title": "Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus.", "journal": "Biochem Pharmacol", "authors": ["Miñano S", "Moleón J", "González-Correa C", "Jiménez R", "Gómez-Guzmán M", "Martín-Morales N", "O'Valle F", "Romero M", "Toral M", "Duarte J"], "date": "2025-07-12T00:00:00Z", "doi": "10.1016/j.bcp.2025.117154", "meta_date_publication": "2025 Jul 12", "meta_volume": "241", "meta_issue": "", "meta_pages": "117154", "score": 50253.125, "text_hl": "This study explores whether pharmacological interventions targeting dysfunctional immune cell metabolism can confer vascular protection in a genetic @SPECIES_10090 @@@mouse@@@ model of @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@SLE@@@. Female NZBWF1 @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus@@@ @SPECIES_10090 @@@mice@@@, aged 29 weeks, were treated for 4 weeks with either a vehicle (@<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@SLE@@@ group), a combination of @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2-deoxy-D-glucose@@@ (@CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2DG@@@) and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@), or @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@rapamycin@@@. ", "citations": {"NLM": "Miñano S, Moleón J, González-Correa C, Jiménez R, Gómez-Guzmán M, Martín-Morales N, O'Valle F, Romero M, Toral M, Duarte J. Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus. Biochem Pharmacol. 2025 Jul 12;241():117154. PMID: 40659125", "BibTeX": "@article{40659125, title={Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus.}, author={Miñano S and Moleón J and González-Correa C and Jiménez R and Gómez-Guzmán M and Martín-Morales N and O'Valle F and Romero M and Toral M and Duarte J}, journal={Biochem Pharmacol}, volume={241}, pages={117154}}"}}, {"_id": "34403367", "pmid": 34403367, "pmcid": "PMC8525586", "title": "Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice", "journal": "JCI Insight", "authors": ["Wilson CS", "Stocks BT", "Hoopes EM", "Rhoads JP", "McNew KL", "Major AS", "Moore DJ"], "date": "2021-10-08T00:00:00Z", "doi": "10.1172/jci.insight.143245", "meta_date_publication": "2021 Oct 8", "meta_volume": "6", "meta_issue": "19", "meta_pages": "", "score": 50250.33, "text_hl": "A 2-week course of @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2DG@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, when combined with tolerance-inducing therapy anti-@GENE_PTPRC @GENE_19264 @@@CD45RB@@@, prevented renal deposition of autoantibodies for 6 months after initial treatment and restored tolerance induction to allografts in @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@lupus@@@-prone @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Wilson CS, Stocks BT, Hoopes EM, Rhoads JP, McNew KL, Major AS, Moore DJ. Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice JCI Insight. 2021 Oct 8;6(19):. PMID: 34403367", "BibTeX": "@article{34403367, title={Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice}, author={Wilson CS and Stocks BT and Hoopes EM and Rhoads JP and McNew KL and Major AS and Moore DJ}, journal={JCI Insight}, volume={6}, number={19}}"}}, {"_id": "40028423", "pmid": 40028423, "title": "Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review.", "journal": "Clin Transl Radiat Oncol", "authors": ["Portillo EGD", "Olivares-Hernández A", "Gudino LC", "Félix LC", "Hernández LB", "Domínguez LP", "Jiménez DL", "Sarmiento RG", "Morillo EDB", "Sánchez EF", "Miramontes-Gonzáleze JP"], "date": "2025-02-10T00:00:00Z", "doi": "10.1016/j.ctro.2025.100930", "meta_date_publication": "2025 May", "meta_volume": "52", "meta_issue": "", "meta_pages": "100930", "score": 50249.836, "text_hl": "The greatest benefits were observed in @DISEASE_Prostatitis @DISEASE_MESH:D011472 @@@prostate tumors@@@ both in OS and @<m>DISEASE_Lupus_Erythematosus_Systemic</m> @DISEASE_MESH:D008180 @@@SLE@@@. Conclusions: The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in combination with radiotherapy in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@solid tumors@@@ is one of the most promising treatments under development in oncology. ", "citations": {"NLM": "Portillo EGD, Olivares-Hernández A, Gudino LC, Félix LC, Hernández LB, Domínguez LP, Jiménez DL, Sarmiento RG, Morillo EDB, Sánchez EF, Miramontes-Gonzáleze JP. Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review. Clin Transl Radiat Oncol. 2025 May;52():100930. PMID: 40028423", "BibTeX": "@article{40028423, title={Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review.}, author={Portillo EGD and Olivares-Hernández A and Gudino LC and Félix LC and Hernández LB and Domínguez LP and Jiménez DL and Sarmiento RG and Morillo EDB and Sánchez EF and Miramontes-Gonzáleze JP}, journal={Clin Transl Radiat Oncol}, volume={52}, pages={100930}}"}}]}